1. Australia Stocks

  2. •

    Health technology

  3. •

    Biotechnology
LTR Pharma Limited

LTR Pharma Limited

AASX:LTP
0.48
AUD
+0.00
(-1.03%)
-0.03EPS
52.48MMarket Cap
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
-0.01
-0.01
-0.05
-0.03
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Book Value per Share
- -
0.01
0.05
0.02
0.17
Tangible Book Value per Share
- -
0.01
0.05
0.02
0.17
Basic Weighted Avg Shares
139
139
139
139
167
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
-5,123.89
Depreciation Expense
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-1
-1
-7
-6
Effective Tax Rate (%)
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
-3,837.01
Working Capital
- -
1
7
3
31
LT Debt
- -
- -
- -
- -
- -
Total Equity
- -
2
7
3
32
Return on Invested Capital (%)
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-31.43
-133.37
-32.47

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
971.58%
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
-19.57%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.01
2024
- -
- -
-0.05
2025
- -
- -
-0.03

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -

Company Description

Company Profile APIChatGPT
Sector
Health technology
Industry
Biotechnology
Address
29/97 Creek Street Brisbane QLD Australia 4000
IPO Date
Dec 11, 2023
Website
ltrpharma.com
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
LTR Pharma Ltd. is a clinical-stage biopharmaceutical company, which engages in the provision of improving men’s health, physically and mentally, through the commercialization of an intranasal spray treatment for Erectile Dysfunction. The company was founded by Rodne Eric Lee in October 2020 and is headquartered in Brisbane, Australia.

Company News

Company News APIChatGPT

  • gurufocus.com

    Roxus® ED Nasal Spray Now Available in the U.S.: Peak Blood Levels in About 10 Minutes, Not an Hour

  • prnewswire.com

    Roxus® ED Nasal Spray Now Available in the U.S.: Peak Blood Levels in About 10 Minutes, Not an Hour